The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998

• Citation: S.I. 1998/1178
• Sections: 3

Section 1 Citation, commencement and interpretation

(1) This Order may be cited as the Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 and shall come into force on 1st June 1998, except for article 2(d)(ii) which shall come into force on 16th September 1998.

(2) In this Order “the principal Order ” means the Prescription Only Medicines (Human Use) Order 1997 .

Section 2 Amendment of Schedule 1 to the principal Order

In Schedule 1 to the principal Order (which specifies substances which when included in medicinal products make those products prescription only medicines and exemptions from restrictions on the sale and supply of prescription only medicines)—

(a) in relation to the substance Domperidone Maleate, there are inserted the following entries—

in column 3

For the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn,

in column 4

10mg (MD)

40mg (MDD)

and in column 5

Container or package containing not more than 100mg of Domperidone as Domperidone Maleate;

in relation to the substance Minoxidil, there are substituted for the entry in column 2 the entries—

(1) 2.0 per cent

(2) 5.0 per cent

and for the entry in column 3 the entries—

(1) External

(2) External use for the treatment of alopecia androgenetica, in men aged 18 to 65 (but not in women);

in relation to the substance Nizatidine—

there are inserted in the entry in column 3, after the word “prevention”, the words “and treatment”, and after the word “heartburn”, the words “and meal-induced indigestion”,

there is inserted in column 4, after the entry “75mg (MD)”, the entry “150mg (MDD)”, and

there is substituted in column 4 for the entry “Maximum of 4 such doses in any period of 14 days”, the entry “For a maximum period of 14 days”; and

there is inserted in column 1, at the appropriate point in the alphabetical order of the entries in that column, each of the following substances—

“Pirenzepine Dihydrochloride Monohydrate”

“Quinapril Hydrochloride” and

“Phenolphthalein.”

Section 3 Amendment of Schedule 5 to the principal Order

In Part III of Schedule 5 to the principal Order there is inserted in the entry in column 2 of paragraph 9, after the words “Anhydrous Glucose”, the words “Bretylium Tosylate”.